Background: Osteosarcoma (OS) is a common bone malignant tumor, which is the eighth leading form
of pediatric cancer. Despite the modern chemotherapeutic development of OS, a number of patients with OS have
a high risk of lung metastasis and local relapse after chemotherapy.
Objective: This review study focused on the role of long non coding RNAs (lncRNAs) in OS progression, and
presented update reports on OS treatment by targeting specific lncRNAs.
Method: We have acquired information on OS and lncRNAs from scientific databases like google scholar,
pubmed and scopus, and reviewed for this study.
Results: The lncRNAs regulate a number of biological processes, and abnormal expression of lncRNAs could play
role in many cancers and other human diseases. Interestingly, some lncRNAs can act as oncogenes, while some act
as tumor suppressor genes. A number of studies revealed that targeting the specific lncRNAs by RNA interferance
technology may provide a novel therapeutic strategy in the treatment of OS.
Conclusion: LncRNAs could be a promising biomarker and might be a potential therapeutic target in OS patients.